Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in Crohn's Disease (CD)

NCT01105741 is registered in ClinicalTrials.gov with Martin Storr as lead sponsor.

NCT NCT01105741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01105741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in Crohn's Disease (CD)
Lead sponsor
Martin Storr
Phase
Observational
Overall status
Completed
Start date
June 30, 2010
Completion date
December 31, 2013
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease